Urgent need to increase global AMR R&D collaboration
The increasing emergence and spread of antimicrobial resistance (AMR) have been discussed in many countries and at a range of international fora including the United Nations (UN) General Assembly, the World Health Assembly, the G7 and the G20 resulting in high political interest and commitment.
As highlighted by the Interagency Coordination Group on Antimicrobial Resistance’s 2019 report to the Secretary-General of the UN No Time to Wait: Securing the Future from Drug-Resistant Infections, urgent action is needed to increase global antimicrobial resistance (AMR) research and development (R&D) coordination and collaboration in an One Health context. The report highlights the need for additional and sustained collaboration between government, funders, the private sector and civil society to accelerate R&D, pull new products through to market and ensure effective stewardship.
In July 2017, the G20 called for a new international R&D Collaboration Hub to maximise the impact of existing and new basic and clinical antimicrobial research initiatives as well as product, which led to the establishment of the Global AMR R&D Hub. The Global AMR R&D Hub is ideally placed to help drive and coordinate the improvement of global AMR R&D collaboration across all One Health sectors.
To help guide the Global AMR R&D Hub’s collaborations, both globally and individually, a draft Collaboration Framework was developed and released for public consultation from 2 September to 10 October 2019. Through this consultation, suggestions and feedback were invited on how improved coordination and collaboration of AMR R&D could be realised. Views were also sought on the Global AMR R&D Hub’s approach to collaboration and suggestions on how this can be enhanced. It is anticipated that the final Collaboration Framework and supporting appendix, that will outline what collaboration mechanisms will be implemented, will be published here in early 2020.
Results of the public consultation
The Global AMR R&D Hub would like to thank everyone who responded to the public consultation on the draft Collaboration Framework. We are pleased to report that 121 responses were included in the analysis presented in the anonymized and aggregated summary of the public consultation results. The key messages that arose from the feedback received included:
- strong agreement that greater coordination and collaboration is needed of global AMR R&D to reduce duplication of resources and efforts
- the highest priority area for improving coordination and collaboration for AMR &D was between One Health sectors and the biggest barrier to achieving this was that each sector has different priorities
- agreement that the four high level areas identified in the draft Collaboration Framework were important for improving coordination and collaboration and suggestions and examples were provided on what could be included or adapted under these areas, and
- that the Global AMR R&D Hub must take a truly global and One Health approach and be output orientated.